Biotechnology Business Investment Opportunities in Maharashtra

- Have catered to 60+ clients. We have clients from 6 different countries. - We have tied up with a network of 150 hospitals across 30 cities to conduct the trials. - The clinical trials are conducted in multiple sites. - We have 13 ongoing collaborations with pharmaceutical companies or research institutions. - Average duration of the clinical trials is 5 months. - We abide by the ICH-GCP guidelines to handle the confidentiality and privacy of participants' data during and after the trial. - One project takes 4-5 months and we receive the entire amount post-completion of the project itself.

- We do the R&D for big pharma companies. - Innovative formulation development with a focus on quality-by-design principles for precise and effective therapeutic solutions. - Commitment to excellence reflected in crafting products that redefine healthcare standards. - Fusion of innovation and precision, guided by scientific rigor, transforming pharmaceutical science into life-changing solutions. - Expertise in product development, CDMO, CMO, and TT services for five major clients, including big pharma companies. - Promoters bring 15 years of experience in R&D and product development. - Client base includes European companies, demonstrating international reach. - Regulatory approvals from the FDA and ISO 17025 underscore the company's commitment to quality and compliance. - Adaptive workforce with contract workers based on demand. - High growth attributed to the acquisition of new clients, showcasing the company's expanding market presence.

- We are a biopharma company dealing in the research and development of various formulations and clinical trials. - As of now the company has rights of 15 formulations and has a large market share in this industry. - Our company has two revenue models. We treat patients majorly from the countries such as Australia, Canada, and the USA using our technology. - These patients especially travel to India for our treatments. - We don't have our own clinics but subcontract hospitals in Mumbai to use our technology. - Another revenue source is to supply our formulations and technology to various other hospitals & clinics and receive a royalty from them. - We also have discussions going on with various insurance companies to provide coverage for our treatments. - Since the majority of our clients are from the USA we are planning to start a drug manufacturing unit there. - This unit will be under the USFDA regulations which would increase our scope to expand into various other international markets. - The company has two partners with a 70% and 30% stake distribution. - Business has not taken any loans previously. - We are seeking investment to establish the manufacturing unit.